BOPI 02 BR / 2025 REPERTOIRE NUMERIQUE 29 ________________________________________ (11) 21818 Consulter le mémoire (51) A23L 33/18 (2023.01); A61K 38/00 (2023.01); A61P 3/10 (2023.01); C07K 7/06 (2023.01) (21) 1202400353 - PCT/KR2022/005466 (22) 15/04/2022 (30) KR n° 10-2022-0036947 du 24/03/2022 (54) Peptide having antidiabetic activity, peptide complex, and use thereof. (72) CHUNG, Yong Ji (KR) (73) CAREGEN CO., LTD., 46-38, LS-ro 91beongil, Dongan-gu, Anyang-si, GYEONGGI-DO 14119, Korea (Republic of) (KR) (74) S.C.P AKKUM, AKKUM & Associates, No. 1777, rue 6.261, Yaoundé 2, Auditorium Jean Paul II boulevard, Face Brigade de Gendarmerie, Mbankolo, B.P. 4966, YAOUNDE (CM). (57) The present invention relates to a peptide complex having an antidiabetic activity and to a use thereof. The peptide complex of the present invention promotes uptake of glucose into cells, suppresses insulin resistance signals, promotes insulin sensitivity signals, and suppresses the death of pancreatic beta cells, which are insulinproducing cells, thereby exhibiting an effect of lowering blood glucose levels. In addition, the present invention relates to a peptide having an antidiabetic activity and an antiobesity activity and to a use thereof. The peptide of the present invention has an activity of suppressing insulin resistance signals, promoting insulin sensitive signals, and promoting fat decomposition in adipocytes. Figure 1a ________________________________________ (11) 21819 Consulter le mémoire (51) C07C 211/20 (2023.01); C07C 217/08 (2023.01); C07C 57/20 (2023.01); C07C 59/01 (2023.01)
RkJQdWJsaXNoZXIy MTM1NDc3MA==